{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:09:59Z","timestamp":1747202999538,"version":"3.40.5"},"reference-count":24,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,9]]},"DOI":"10.20945\/2359-3997000000292","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T18:57:51Z","timestamp":1603306671000},"source":"Crossref","is-referenced-by-count":1,"title":["Lipid profile and response to statin therapy in patients with hypopituitarism"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8838-7040","authenticated-orcid":false,"given":"Graziela","family":"Rissetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2041-4302","authenticated-orcid":false,"given":"D\u00e9bora","family":"Zeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7953-2952","authenticated-orcid":false,"given":"B\u00e1rbara Roberta","family":"Ongaratti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8207-9119","authenticated-orcid":false,"given":"J\u00falia Fernanda Semmelmann","family":"Pereira-Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4603-6968","authenticated-orcid":false,"given":"Carolina Garcia Soares Le\u00e3es","family":"Rech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7091-513X","authenticated-orcid":false,"given":"Miriam da Costa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"key":"key20201021145749_B1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-2265.2012.04516.x","article-title":"Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients","volume":"78","author":"Fernandez-Rodrigues","year":"2013","unstructured":"1. Fernandez-Rodrigues E, Lopez-Raton M, Andujar P, Martinez-Silva IM, Cadarso-Suarez C, Casanueva FF, et al. Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients. Clin Endocrinol. 2013;78:278-84.","journal-title":"Clin Endocrinol"},{"key":"key20201021145749_B2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","article-title":"Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain","volume":"55","author":"Regal","year":"2001","unstructured":"2. Regal M, Paramo C, Sierra SM. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol. 2001;55:735-40.","journal-title":"Clin Endocrinol"},{"key":"key20201021145749_B3","first-page":"23","volume-title":"Endocrinologia Cl\u00ednica","author":"Naves","year":"2009","unstructured":"3. Naves LA, Junior ARO, Vilar L. Hipopituitarismo \u2013 Diagn\u00f3stico e tratamento. Vilar L, Kater CE, Naves LA, Freitas MC, Bruno OD (eds). Endocrinologia Cl\u00ednica. 4\u00aa ed. Rio de Janeiro: Guanabara Koogan; 2009. p. 23-36.","edition":"4\u00aa ed."},{"key":"key20201021145749_B4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1530\/EJE-11-0599","article-title":"Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis","volume":"165","author":"Verhelst","year":"2011","unstructured":"4. Verhelst J, Mattson AF, Luger A, Thunander M, G\u00f3th MI, Koltowska-Haggstrom M. Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. Eur J Endocrinol. 2011;165:881-9.","journal-title":"Eur J Endocrinol"},{"key":"key20201021145749_B5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ghir.2013.04.001","article-title":"Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism","volume":"23","author":"Prodam","year":"2013","unstructured":"5. Prodam F, Gasco V, Caputo M, Zavattaro M, Pagano L, Marzullo P, et al. Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism. Growth Horm IGF Res. 2013;23:109-13.","journal-title":"Growth Horm IGF Res"},{"key":"key20201021145749_B6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism","volume":"357","author":"Tomlinson","year":"2001","unstructured":"6. Tomlinson JW, Holden N, Hills RK, Whetley K, Clayton RN, Bates AS, et al. Association between premature mortality and hypopituitarism. Lancet. 2001;357:425-31.","journal-title":"Lancet"},{"key":"key20201021145749_B7","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy","volume":"89","author":"Svensson","year":"2004","unstructured":"7. Svensson J, Bengtson BA, Ros\u00e9n T, Oden A, Johannsson G. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J Clin Endocrinol Metab. 2004;89:3306-12.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20201021145749_B8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/jc.2009-1326","article-title":"Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement","volume":"95","author":"Attanasio","year":"2010","unstructured":"8. Attanasio AF, Mo D, Erfurth EM. Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement. J Clin Endocrinol Metab. 2010;95:74-81.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20201021145749_B9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1210\/jc.2012-2940","article-title":"Metabolic profile in growth hormone deficient adults after long-term recombinant human growth hormone therapy","volume":"98","author":"Claessen","year":"2013","unstructured":"9. Claessen KM, Appelman-Dijkstra NM, Adoptie DM, Roelfsema F, Smit JW. Metabolic profile in growth hormone deficient adults after long-term recombinant human growth hormone therapy. J Clin Endocrinol Metab. 2013;98:352-61.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20201021145749_B10","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1530\/EJE-09-0291","article-title":"Cardiovascular risk factors in hypopituitary GH-deficient adults","volume":"161","author":"Verhelst","year":"2009","unstructured":"10. Verhelst J, Abs R. Cardiovascular risk factors in hypopituitary GH-deficient adults. Eur J Endocrinol. 2009;161(Suppl 1):S41-9.","journal-title":"Eur J Endocrinol"},{"key":"key20201021145749_B11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11102-016-0747-9","article-title":"Sex differences in the prevalence of metabolic syndrome and its components in hypopituitary patients: comparison with an age- and sex-matched nationwide control group","volume":"19","author":"Khang","year":"2016","unstructured":"11. Khang AR, Ku EJ, Kim YA, Roh E, Bae JH, Oh TJ, et al. Sex differences in the prevalence of metabolic syndrome and its components in hypopituitary patients: comparison with an age- and sex-matched nationwide control group. Pituitary. 2016;19:573-81.","journal-title":"Pituitary"},{"key":"key20201021145749_B12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1507\/endocrj.50.759","article-title":"Hypercholesterolemia and obesity in adult patients with hypopituitarism: a report of a nation-wide survey in Japan","volume":"50","author":"Murakami","year":"2003","unstructured":"12. Murakami Y, Kato Y. Hypercholesterolemia and obesity in adult patients with hypopituitarism: a report of a nation-wide survey in Japan. Endocr J. 2003;50:759-65.","journal-title":"Endocr J"},{"key":"key20201021145749_B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5935\/abc.2013S010","article-title":"V Diretriz Brasileira de Dislipidemia e Preven\u00e7\u00e3o da Aterosclerose","volume":"101","author":"Xavier","year":"2013","unstructured":"13. Xavier HT, Izar MC, Neto JRF, Assad MH, Rocha VZ, Sposito AC, et al. V Diretriz Brasileira de Dislipidemia e Preven\u00e7\u00e3o da Aterosclerose. Arq Bras Cardiol. 2013;101:1-22.","journal-title":"Arq Bras Cardiol"},{"key":"key20201021145749_B14","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1210\/jc.2011-1215","article-title":"Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in adults","volume":"96","author":"van Bunderen","year":"2011","unstructured":"14. van Bunderen CC, van Nieuwpoort IC, Arwert LI, Heymans ME, Franken AA, Koppeschaar HP, et al. Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in adults. J Clin Endocrinol Metab. 2011;96:3151-9.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20201021145749_B15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1530\/EJE-11-1028","article-title":"Overall and cause-specific mortality in GH-deficient adults on GH replacement","volume":"166","author":"Gaillard","year":"2012","unstructured":"15. Gaillard RC, Mattsson AF, Akerblad AC, Bengtsson B\u00c5, Cara J, Feldt-Rasmussen U, et al. Overall and cause-specific mortality in GH-deficient adults on GH replacement, Eur J Endocrinol. 2012;166:1069-77.","journal-title":"Eur J Endocrinol"},{"key":"key20201021145749_B16","first-page":"1169","article-title":"The effect of hypopituitarism on life expectancy","volume":"81","author":"Bates","year":"1996","unstructured":"16. Bates AS, Van\u2019t Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 1996;81:1169-73.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20201021145749_B17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism","volume":"46","author":"B\u00fclow","year":"1997","unstructured":"17. B\u00fclow B, Hagmar L, Mikoczy Z, Nordstr\u00f6m CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol. 1997;46:75-81.","journal-title":"Clin Endocrinol"},{"key":"key20201021145749_B18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090602","article-title":"High prevalence of metabolic syndrome features in patients previously treated for nonfunctioning pituitary macroadenoma","volume":"9","author":"Joustra","year":"2014","unstructured":"18. Joustra SD, Claessen KM, Dekkers OM, van Beek AP, Wolffenbuttel BHR, Pereira AM. High prevalence of metabolic syndrome features in patients previously treated for nonfunctioning pituitary macroadenoma. PLoS One. 2014;9:e90602.","journal-title":"PLoS One"},{"key":"key20201021145749_B19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1507\/endocrj.K06-129","article-title":"Hormone replacement therapy and vascular risk disorders in adult hypopituitarism","volume":"54","author":"Kaji","year":"2007","unstructured":"19. Kaji H, Iida K, Takahashi Y, Okimura Y, Chihara K. Hormone replacement therapy and vascular risk disorders in adult hypopituitarism. Endocr J. 2007;54:239-45.","journal-title":"Endocr J"},{"key":"key20201021145749_B20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2265.2007.02935.x","article-title":"Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy","volume":"67","author":"Monson","year":"2007","unstructured":"20. Monson JP, Jonsson P, Koltowska-Haggstrom M, Kourides I. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy. Clin Endocrinol. 2007;67:623-8.","journal-title":"Clin Endocrinol"},{"key":"key20201021145749_B21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ijrobp.2013.03.034","article-title":"Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study","volume":"86","author":"Mueller","year":"2013","unstructured":"21. Mueller S, Fullerton HJ, Stratton K, Leisenring W, Weathers RE, Stovall M, et al. Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys. 2013;86:649-55.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20201021145749_B22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3857\/roj.2011.29.3.156","article-title":"Radiotherapy for pituitary adenomas: long-term outcome and complications","volume":"29","author":"Rim","year":"2011","unstructured":"22. Rim CH, Yang DS, Park YJ, Yoon WS, Lee JA, Kim CY. Radiotherapy for pituitary adenomas: long-term outcome and complications. Radiat Oncol J. 2011;29:156-63.","journal-title":"Radiat Oncol J"},{"key":"key20201021145749_B23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1590\/S0034-89102009000900011","article-title":"Preval\u00eancia de excesso de peso e obesidade e fatores associados, Brasil, 2006","volume":"43","author":"Gigante","year":"2009","unstructured":"23. Gigante DP, Moura EC, Sardinha LMV. Preval\u00eancia de excesso de peso e obesidade e fatores associados, Brasil, 2006. Rev Sa\u00fade P\u00fablica. 2009;43(Supl 2):83-9.","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"key20201021145749_B24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1590\/S0066-782X2011005000083","article-title":"Preval\u00eancia de dislipidemia em indiv\u00edduos fisicamente ativos durante a inf\u00e2ncia, adolesc\u00eancia e idade adulta","volume":"97","author":"Fernandes","year":"2011","unstructured":"24. Fernandes RA, Christofaro DGD, Casonatto J, Codogno JS, Rodrigues EQ, Cardoso ML, et al. Preval\u00eancia de dislipidemia em indiv\u00edduos fisicamente ativos durante a inf\u00e2ncia, adolesc\u00eancia e idade adulta. Arq Bras Cardiol. 2011;97:317-23.","journal-title":"Arq Bras Cardiol"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T22:08:15Z","timestamp":1698271695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972020005007201&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":24,"alternative-id":["10.20945\/2359-3997000000292"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000292","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"type":"print","value":"2359-3997"},{"type":"electronic","value":"2359-4292"}],"subject":[],"published":{"date-parts":[[2020,10,9]]}}}